Faculty home

Pharmacy and Pharmaceutical Sciences

Only through community and collaboration can we achieve the best possible results. Together we aim to shift gears and change old ways of thinking. And we need people like you – your skills, your perspectives, your passion.

Stay up-to-date with the latest news from inside the world of Pharmacy and Pharmaceutical Sciences.

MIPS researcher elected Fellow of the Australian Academy of Health and Medical Sciences (AAHMS)

19 October 2017

Professor Arthur Christopoulos has been named a Fellow of the Australian Academy of Health and medical Sciences (AAHMS).

MIPS researchers’ world first reveals structure of important drug target

In a paper published today in the influential journal Nature, researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University discuss the use of a novel technique to reveal the structure of an important drug target.

MIPS researcher awarded fellowship to enhance anti-parasitic drug discovery

Monash Institute of Pharmaceutical Sciences’ (MIPS) Dr Darren Creek has been awarded a NHMRC R.D. Wright Biomedical Career Development Fellowship. The Fellowship will support his work to improve our understanding of how current antimalarial drugs work and identify new ways drugs can kill malaria parasites. The Fellowship is valued at $476,728 over four years.

MIPS partner, Starpharma, announces positive phase 1 clinical results for DEP® Docetaxel

11 October 2017

Scientists within Professor Chris Porter’s group at the ARC Centre of Excellence for Convergent Bio-Nano Science and Technology at the Monash Institute of Pharmaceutical Science have been working for a number of years with the Australian Biotechnology company, Starpharma, to develop advanced drug delivery systems. One result of those programs has been the development of the DEP® delivery platform with broad application including for improved cancer treatments. The DEP® delivery technology, based on Starpharma’s star-shaped polymers or dendrimers, has been shown to improve drug efficacy and reduce toxicity in a number of pre-clinical oncology models.  Starpharma has applied this technology in its own development programs (such as DEP® docetaxel) and in partnership with pharmaceutical companies, for example AstraZeneca (see http://starpharma.com/news/340).

Medicine Manufacturing

MMIC Advisory Board to help Victorian Manufacturing Innovate

10 October 2017

Monash University’s Medicines Manufacturing Innovation Centre (MMIC) announced the members of its Industry Advisory Board. Following the announcement an expert panel asked if pharmaceutical manufacturing is keeping pace with the advances of 21st century medicine. The event was hosted by the BioMelbourne Network.

View more articles